Jack Bergman
Impact in
- Cellular and Molecular Neuroscience top 0.5%
- Neurotransmitter Receptor Influence on Behavior
- Neuropeptides and Animal Physiology
- Neuroscience and Neuropharmacology Research
- Pharmacology top 1%
- Cannabis and Cannabinoid Research
Papers in
-
- Neurotransmitter Receptor Influence on Behavior 98
- Neuropeptides and Animal Physiology 18
- Pharmacology 34
- Cannabis and Cannabinoid Research 28
- Co-authors
- Roger D. Spealman (19 shared papers)Bertha Kalifon Madras (12 shared papers)Brian D. Kangas (33 shared papers)Carol Anne Paronis (28 shared papers)Rajeev I. Desai (14 shared papers)Nancy K. Mello (10 shared papers)Jonathan B. Kamien (3 shared papers)Alexandros Makriyannis (22 shared papers)
- Journals
- Journal of Pharmacology and Experimental Therapeutics (42 papers)Psychopharmacology (26 papers)Behavioural Pharmacology (15 papers)The FASEB Journal (8 papers)Neuropsychopharmacology (8 papers)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Jack Bergman
166 papers receiving 4k citations
Peers
Comparison fields: 5 of 98
- Cellular and Molecular Neuroscience 2.6k
- Pharmacology 642
- Biological Psychiatry 45
- Toxicology 70
- Behavioral Neuroscience 32
Countries citing papers authored by Jack Bergman
This map shows the geographic impact of Jack Bergman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack Bergman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack Bergman more than expected).
Fields of papers citing papers by Jack Bergman
This network shows the impact of papers produced by Jack Bergman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack Bergman. The network helps show where Jack Bergman may publish in the future.
Co-authors
The 25 scholars most cited alongside Jack Bergman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 171 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 374 | |
| 2 | 1990 | 185 | |
| 3 | 1991 | 132 | |
| 4 | 1999 | 128 | |
| 5 | 2012 | 114 | |
| 6 | 1992 | 112 | |
| 7 | 1996 | 89 | |
| 8 | 2012 | 88 | |
| 9 | 2013 | 85 | |
| 10 | 1994 | 69 | |
| 11 | 1998 | 69 | |
| 12 | 2002 | 63 | |
| 13 | 2016 | 62 | |
| 14 | 2004 | 55 | |
| 15 | 2007 | 55 | |
| 16 | 2017 | 54 | |
| 17 | 1985 | 48 | |
| 18 | 1986 | 48 | |
| 19 | 1988 | 46 | |
| 20 | 1996 | 46 |
About Jack Bergman
Jack Bergman is a scholar working on Cellular and Molecular Neuroscience, Pharmacology, Cognitive Neuroscience, Physiology and Molecular Biology, having authored 171 papers that have together received 4.1k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (98 papers), Cannabis and Cannabinoid Research (28 papers), Neuropeptides and Animal Physiology (18 papers), Nicotinic Acetylcholine Receptors Study (9 papers), Opioid Use Disorder Treatment (8 papers), Smoking Behavior and Cessation (7 papers), Neural and Behavioral Psychology Studies (7 papers) and Substance Abuse Treatment and Outcomes (7 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (2.6k citations), Pharmacology (642 citations), Biological Psychiatry (45 citations), Toxicology (70 citations) and Behavioral Neuroscience (32 citations). Jack Bergman has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Roger D. Spealman, Bertha Kalifon Madras, Brian D. Kangas, Carol Anne Paronis, Rajeev I. Desai, Nancy K. Mello, Jonathan B. Kamien, Alexandros Makriyannis, Sharon J. Rosenzweig-Lipson and Stephen John Kohut. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Psychopharmacology, Behavioural Pharmacology, The FASEB Journal and Neuropsychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.